# Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer

Article · Christine Feig, James O. Jones, Matthew Kraman, Richard J. B. Wells, Andrew Deonarine, Derek S. Chan, Claire M. Connell, Edward W. Roberts, Qi Zhao, Otávia L. Caballero, Sarah Amalia Teichmann, Tobias Janowitz, Duncan Ian Jodrell, David Arthur Tuveson, Douglas T. Fearon

- Archive id: doi:10.1073/pnas.1320318110
- Published: 2013-11-25
- Venue: Proceedings of the National Academy of Sciences
- DOI: https://doi.org/10.1073/pnas.1320318110
- PMID: 24277834
- Citations: 2,098
- Source URL: https://doi.org/10.1073/pnas.1320318110
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.